About MeI am a professor of gynecologic oncology at The Ohio State University and have been in practice since 1991. I have extensive expertise in the latest surgical techniques including radical pelvic surgery, pelvic reconstruction and minimally invasive surgery including laparoscopic and robotic surgery. I am also the medical director for the Robotic Surgery Program at The Ohio State University Medical Center. I have taught these techniques to other surgeons locally, nationally and internationally. I was rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016 and 2017. I have served as chief of staff for the James Cancer Hospital and currently serve as vice-chair of the Department of Obstetrics and Gynecology.
I grew up in Michigan and attended Kalamazoo College and then graduated from Northwestern University Medical School in Chicago. I completed my residency at The Ohio State University College of Medicine and pursued a fellowship in gynecologic oncology at the UCLA School of Medicine and Cedars-Sinai in Los Angeles. After fellowship, I joined the faculty of the University of Minnesota Hospital and Clinic as an assistant professor. In 1997, I returned to The Ohio State University College of Medicine as an associate professor of obstetrics and gynecology and served as director of the Division of Gynecologic Oncology through 2010. In 2001, I was named the inaugural holder of the John G. Boutselis Chair in Gynecologic Oncology, and in 2002 was promoted to full professor.
I represented The Ohio State University in many leadership roles. I serve as a board examiner for general obstetrics and gynecology and gynecologic oncology sub-specialty oral exams for the American Board of Obstetrics and Gynecology (ABOG) and completed a six-year term as board member for ABOG’s Division of Gynecologic Oncology. I served on the Board of Governors of the American College of Surgeons and most recently as the president of the Society of Gynecologic Oncology.
I have authored or co-authored more than 180 journal articles and numerous book chapters and abstracts presented at scholarly meetings. I am a member of the editorial boards for Gynecologic Oncology and the Journal of Robotic Surgery. My primary research interests have been in advancing the state of the art of surgery in gynecologic oncology including minimally invasive surgery (first laparoscopy and now robotics), radical pelvic surgery and pelvic reconstructive surgery.
I have received several awards recognizing my excellence in medical student and resident teaching at Ohio State. I have also been recognized for my research presentations. I have been listed among the "Best Doctors in America" for the past 20 years.
- Named to the Castle Connolly list of America’s “Top Doctors” for 2015 and 2017
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2014, 2016, 2017
- Best Doctor in America 2017
Specialties and conditions I treat
- Gynecologic Oncology
- Gynecologic Cancers
- Ovarian Cancers
- Uterine Cancers
- Minimally Invasive Surgical Procedures
- Endometrial Cancers
- Cervical Cancer
- Vaginal Cancers
- Vulvar Cancers
Locations where I practice
Education and training
Northwestern University Medical School
Obstetrics / Gynecology
Ohio State University Wexner Medical Center
7/1/1985 - 6/30/1989
More about my work
American Board of OB/GYN
American Board of OB/GYN (Subspecialty: Gynecologic Oncology)
News about me
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/2017, Dr. Fowler has reported no financial relationships with medical device, research and/or drug companies.